BlueWind Reprieve System for the Treatment of PNP
Safety and Performance of the BlueWind Medical Reprieve System for the Treatment of Patients With Peripheral Neuropathic Pain
Sponsor: BlueWind Medical
This NA trial investigates Peripheral Neuropathic Pain and is currently completed. BlueWind Medical leads this study, which shows 8 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
May 2020 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — May 2020 [monthly]
Completed NA
▶ Show 3 earlier versions
-
May 2018 — Jun 2018 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jun 2017 — May 2018 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2017 — Jun 2017 [monthly]
Recruiting NA
First recorded
Dec 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- BlueWind Medical
For direct contact, visit the study record on ClinicalTrials.gov .